-
Product Insights
NewMitral Valve Annuloplasty Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Mitral Valve Annuloplasty Devices consist of the annuloplasty rings and bands that are used in the repair of mitral valves. GlobalData's Medical Devices sector report, “Mitral Valve Annuloplasty Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Mitral Valve Annuloplasty Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Mitral...
-
Product Insights
New70S Ribosome – Drugs In Development, 2024
The 70S Ribosome pipeline drugs market research report outlays comprehensive information on the 70S Ribosome targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Respiratory, Central Nervous System, and Genito Urinary System which include indications of Bacterial Infections, Skin And Skin Structure Infections (SSSI) Caused By Bacteria, Cystic Fibrosis, Bronchiectasis, Primary Progressive Multiple Sclerosis (PPMS), Relapsing...
-
Product Insights
New30S Ribosomal Subunit – Drugs In Development, 2024
The 30S Ribosomal Subunit pipeline drugs market research report outlays comprehensive information on the 30S Ribosomal Subunit targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Respiratory, Genito Urinary System, and Ear Nose Throat Disorders which include indications of Skin And Skin Structure Infections (SSSI) Caused By Bacteria, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, Cystic Fibrosis, Bronchiectasis,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avutometinib Potassium in Metastatic Uveal Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avutometinib Potassium in Metastatic Uveal Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avutometinib Potassium in Metastatic Uveal Melanoma Drug Details: Avutometinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VENT-02 in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VENT-02 in Neurodegenerative Diseases report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VENT-02 in Neurodegenerative Diseases Drug Details: VENT-02 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VENT-02 in Neuroinflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VENT-02 in Neuroinflammation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VENT-02 in Neuroinflammation Drug Details: VENT-02 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tomivosertib Hydrochloride in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tomivosertib Hydrochloride in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tomivosertib Hydrochloride in Refractory Acute Myeloid Leukemia Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tomivosertib Hydrochloride in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tomivosertib Hydrochloride in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tomivosertib Hydrochloride in Relapsed Acute Myeloid Leukemia Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSBR-1290 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSBR-1290 in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSBR-1290 in Obesity Drug Details: GSBR-1290 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSBR-1290 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSBR-1290 in Type 2 Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSBR-1290 in Type 2 Diabetes Drug Details: GSBR-1290 is under development...